This test is most useful if any of these apply to you.
If wheat leaves you foggy, bloated, or achy but your basic celiac test came back normal, you are left without an explanation. This panel widens the lens, measuring dozens of antibodies against the many proteins in wheat, not just the one or two a standard test checks.
It also asks whether your gut lining may be letting food and bacterial fragments slip through. Most of these newer markers are still exploratory, so the panel is best read as a detailed map of your immune reaction to wheat rather than a diagnosis.
This panel answers several questions in one draw. Does your body mount the specific autoimmune reaction that defines celiac disease, how broadly does your immune system react across wheat's many proteins, and is your gut barrier letting food and bacterial fragments through? Apart from the celiac markers, most of these answers are exploratory, so read the panel as a detailed map rather than a verdict.
At the center of this panel sit the markers clinicians already trust for celiac disease, an autoimmune reaction to gluten that damages the small intestine. Throughout, two antibody classes are measured: IgA, made mainly at the gut surface, and IgG, which circulates in the blood and still works when someone lacks IgA.
Antibodies to tissue transglutaminase (tTG, an enzyme the immune system wrongly attacks) and to deamidated gliadin peptides (DGP, a processed gluten fragment) are well validated for celiac disease. Measured while you still eat gluten, tTG-IgA performs well in adults, with sensitivity around 90% and specificity that most studies place above 95%, making it the front-line celiac blood test.
Beyond the celiac markers, the panel measures antibodies to a wide range of wheat proteins: the gliadin fractions (alpha, beta, gamma, and omega), the high- and low-molecular-weight glutenins that give dough its stretch, and non-gluten proteins such as wheat germ agglutinin (WGA, a wheat lectin) and amylase-trypsin inhibitors. This breadth can show whether your reaction is narrow, as in classic celiac disease, or spread across many wheat components. These broader markers are not validated diagnostic tests. Despite active research, no specific biomarker for non-celiac wheat sensitivity has been confirmed.
The barrier markers test a different idea: that gluten can loosen the gut lining. When gliadin is present, cells can release zonulin, a protein that opens the seams (tight junctions) between them. If the barrier leaks, bacterial-wall fragments called lipopolysaccharide (LPS) can slip into the blood and stir up inflammation, which is why antibodies to zonulin, to the structural protein actin, and to LPS are included. This mechanism is well described in celiac disease, but the serum barrier markers are hard to interpret: commercial zonulin blood tests may not actually measure zonulin itself, and their levels correlate poorly with directly measured gut leakiness.
A final group looks beyond the gut. Antibodies to transglutaminase 3 (TG3) are the hallmark of dermatitis herpetiformis, an itchy blistering rash driven by gluten, while antibodies to transglutaminase 6 (TG6) are linked to gluten-related balance and coordination problems; TG6 antibodies were found in 73% of people with gluten ataxia in one study, though more recent work has questioned how well they separate gluten-related ataxia from other causes. The panel also includes gluten-derived opioid-like peptides (gluteomorphin and prodynorphin), but human evidence connecting these to symptoms has not been established.
Two rules shape every result. First, these antibodies only appear when you are eating gluten, so testing after weeks gluten-free can read falsely low. Second, if you are deficient in IgA, all the IgA-based markers can look reassuring when they should not, which is why pairing the panel with a total IgA level matters. With that in mind, patterns tell you more than any single number.
| Pattern | What It May Suggest |
|---|---|
| tTG and DGP clearly elevated while eating gluten | Strong celiac signal; confirm with a clinician before changing your diet |
| Gliadin or other wheat antibodies up, but tTG normal | Broader wheat reactivity that is not celiac disease; interpret with symptoms, not as a diagnosis |
| Barrier markers such as zonulin and anti-LPS up alongside wheat antibodies | Possible gut-barrier involvement; exploratory and hypothesis-generating |
| TG3 or TG6 elevated with skin or neurological symptoms | Consider evaluation for the skin or nervous-system forms of gluten sensitivity |
If your celiac markers are clearly elevated, keep eating gluten and see a gastroenterologist promptly, since a firm diagnosis usually needs confirmatory testing such as an endomysial antibody or a small-intestine biopsy while gluten is still in your diet. Adding a total IgA level and an endomysial antibody sharpens the picture. If only the broader wheat or barrier markers are raised, a structured elimination and reintroduction of wheat, guided by a clinician, is more informative than the antibodies alone.
If you already have celiac disease, this panel is useful for tracking. Celiac antibodies are usually rechecked every 6 to 12 months until they normalize, and the trend across draws matters more than any single value. Falling levels suggest your gluten-free eating is working; a rebound can flag hidden gluten exposure.
Several confounders move many markers at once. Starting a gluten-free diet before testing lowers antibodies across the board; in people already off gluten, celiac serology detects persistent intestinal damage with a sensitivity of only 0.50. IgA deficiency depresses every IgA result together. And serum zonulin swings day to day, so one raised reading is weak evidence on its own.
Wheat Zoomer is best interpreted alongside these tests.